Award
Delivery Order #SPE2DR26FSBG9
Delivery Order for XOLAIR Pharmaceutical Supply to Federal Agencies
Buyer
Defense Logistics Agency
Award Amount
$1,579.22
Ceiling
$1,579.22
Awarded
March 06, 2026
Period of Performance
Mar 06, 2026 – Mar 27, 2026
Identifier
SPE2DR26FSBG9
NAICS
424210
This award is a delivery order contract granted to DMS Pharmaceutical Group Inc., a specialized pharmaceutical distributor, under an existing indefinite delivery vehicle (IDV) agreement. The contract focuses on supplying a specific pharmaceutical product, XOLAIR 150 MG/ML syringe, essential for medical treatments. The order supports federal healthcare operations by ensuring timely availability of critical medications. The scope covers the procurement and delivery of the indicated pharmaceutical item to the place of performance in Park Ridge, Illinois, within a brief, defined timeframe. This award arises as a continuation under the parent IDV contract known for pharmaceutical services, streamlining federal acquisition processes. The contract's significance lies in sustaining public health programs through dependable drug supply chains. It was awarded as part of an existing vehicle, and no specific competitive or sole-source details are provided. The performance period is a short-term, focused delivery scheduled for a few weeks in early 2026.
Description
4571112623!XOLAIR 150 MG/ML SYRINGEML